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common. At the time of diagnosis, intrapulmonary metastases were 
found at seven cases (16%) 
Conclusion: Predominant radiologic ﬁnding of PA pattern adenocar-
cinoma is solitary nodule or mass with lobulation and ﬁne speculation. 
Secondary dominant CT feature is central mass or inﬁltration which are 
uncommon in adenocarcinoma. Further investigation is necessary to 
correlate pathologic ﬁndings of these two subtypes. GGO, air-broncho-
gram and consolidation is less common CT ﬁndings. Although it is not 
speciﬁc, there are several characteristic CT features to suggest subtype 
of adenocarcinoma with micropapillary pattern.
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Background: In recent years, clinical use of high-resolution computed 
tomography (CT) has greatly advanced the diagnosis of small lesions of 
the peripheral lung. Such small lesion is often associated with ground-
glass opacity (GGO) in CT ﬁndings. The important issue in the man-
agement of small lung carcinoma, especially those showing pure GGO, 
is the dormant nature of the tumor. Although it has been suggested 
that the adenoma-carcinoma sequence also applies to tumorigenesis in 
adenocarcinoma of the lung, no persuasive data have been presented 
about the percentage of pure GGO lesions that are indolent over a 
long clinical course or the percentage of GGO lesions that progress to 
become solid lesions. The timeframe for small GGO lesions to progress 
to solid tumors is also unclear. To avoid an overdiagnosis bias and un-
necessary surgery, it is important to elucidate the natural history of the 
small lung lesions showing GGO features.
Methods: We investigated clinicopathological ﬁndings of 18 patients 
with small peripheral lung lesions showing pure GGOs or part-solid 
GGOs deﬁned with CT and retained for more than six months. After 
long-term observation, three of 18 patients underwent pulmonary resec-
tion, and 15 are currently being followed. 
Results: The patients comprised six men and 12 women, ranging in 
age from 37 to 80 years. The median follow-up period was 25 months, 
ranging from 6 to 72 months. The size of lesion at the time of ﬁrst 
presentation was 5 to 22 mm in largest diameter. There were 12 patients 
with solitary lesion and six had multiple lesions raging in number 2 to 
20. Of the 18 patients, 10 showed pure GGO on CT and 8 with part-
solid GGO type. During follow-up, the size of lesion showed no change 
(±1mm) in 13 (72%) patients, increased slightly (up to 5mm) in three 
(17%), and increased by more than 5mm and showed new lesions in 
two (11%). Of the 10 patients with pure GGO, 9 showed no change in 
size of the lesion. Three patients underwent limited pulmonary resec-
tion (segmentectomy in two patients and wedge resection in one) with 
negative surgical margin. Of them, two patients had adenocarcinoma 
and one bronchioloalveolar carcinoma. There was no clear tendency 
between the degree of size change and histology. All patients are alive.
Conclusions: Previous reports have often suggested that the manage-
ment of GGO lesions should differ from the management of small, 
peripheral, noncalciﬁed solitary nodules showing soft-tissue density. 
Our data suggest that some small lung lesions, especially showing pure 
GGO, will never progress to clinical disease and might be overdiag-
nosed.
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Comparison of WHO and RECIST criteria for assessment of 
response in patients with lung cancer- A pilot study
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Objective tumor response is a common endpoint in daily practice as 
well as in clinical trials to evaluate the efﬁcacy of anti-cancer agents. 
To maintain uniformity we are following the consensus statements 
for long times. The general sense suggests that any tumor response is 
always three dimensional. However by the application of the math-
ematical models we gradually reduced it to two dimensions (WHO). 
However progress in imaging technology mandated new methodology 
to evaluate response to treatment. One among such is the Response 
Evaluation Criteria in Solid Tumors Group (RECIST) guidelines using 
unidimensional measurement. Theoretically, the simple sum of the 
maximum diameters of individual tumors is not accepted by many on-
cologists as a representative of cell kill than is the sum of the bidimen-
sional products and they prefer 3D. many previous trails have resolved 
this issue and presently the RECIST is considered as gold standard. 
However the practice of radiologists is not uniform and therefore we 
thought of comparing WHO and RECIST criteria 
Methods: A total of 48 previously untreated patients with locally 
advanced or metastatic NSCLC during 2004 to 2006 with an ECOG 
performance status (PS) scale of ? 2 were included. Patients received 
either a combination of Gemcitabine and Cisplatin; Gemcitabine and 
Carboplatin or cisplatin with etoposide. Gemcitabine was given at a 
dosage of 1250mg/m2 on days 1and 8 of a 3 weekly cycle, while Cis-
platin was given at 75-100mg/m2 and Carboplatin at an AUC of 6 once 
every three weeks. Etoposide was given as 100mg/m2 infusion per day 
over 3 days. 
The treatment arms were based on the socioeconomic status of the 
patient.The responses were assessed with either a chest X ray or a CT 
scan again based on the economic status and the method was main-
tained constant all through the study. Response was assessed as per the 
RECIST criteria as well as WHO criteria. Assessment was done at end 
of every 2nd cycle and conﬁrmed after 4 weeks of initial response. The 
tests repeated if clinically indicated.Our study shows the wide discrep-
ancy between the WHO and the RECIST assessment systems and thus 
the need to evaluate on similar scales.
The ideal system seems to be the one that would simply look at the 
volume in a 3 dimensional way.
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The International Staging System,is currently based on prognostic 
data, mainly issued from surgical series. It is generally considered that 
locally advanced non-small cell lung cancers have to be treated by 
multimodal approaches, at least including induction or adjuvant chemo-
therapy, because their propensity to distant metastatic spreading. Pre-
sumably those patients without N2 or N3 lymph node involvement will 
be referred to surgery, because disease progression is more expected at 
the locoregional level. Authors retrospectively reviewed 392 patients 
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with stage IV metastatic non-small cell lung cancers. All patients have 
been prospectively registered with clinical TNM staging. Patients were 
found with N0-1 and N2-3 status in 34% and 66%, respectively. Two 
hundred and twenty patients (56%) were classiﬁed T1-2, while 172 
were found T3-4 (44%). Interestingly 13% of the patients were found 
T1-2N0. 
Conclusion: T and N descriptors by themselves seem to be bad predic-
tors of metastatatic disease in non-small cell lung cancer. 
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Objectives: The purpose of our study was to compare the diagnostic 
efﬁcacies of helical dynamic CT and integrated PET/CT for the predic-
tion of mediastinal nodal metastasis in stage below IIIB non-small cell 
lung cancer (NSCLC). 
Patient and Methods: Sixty one patients (M: F = 48:13, age range 
41-79 ) with NSCLC underwent lobectomy or pneumonectomy 
were included. In enhanced CT, the diagntostic criteria of metastatic 
mediastinal nodes were over 10mm (measured by short axis) lymph 
node without deﬁnite calciﬁcations. In integrated PET/CT, nodes were 
regarded as positive for malignancy when they showed over 2.5 ( in 1 
hr) in maximum standardized uptake value with a discrete margin and 
more 18F-FDG uptake than mediastinal structures. And the retention 
index was acquired by this equation RI (Retention Index) = (SUV 
1h-SUV2h)x100/SUV 1h Sensitivities, speciﬁcities, and accuracies for 
mediastinal nodal metastasis detection were compared with enhanced 
CT and integrated PET/CT, histopathologic results. 
Results: Of the 61 patients, 23 (37%) had positive mediastinal nodes. 
The sensitivity, speciﬁcity for mediastinal nodal metastasis prediction 
on enhanced CT by size criteria alone were 72%, 69%, respectively, 
whereas those on integrated PET/CT were 92 %, 97% by determined 
the initial SUV and retention index.
Conclusions: In NSCLC (operable cases, staege, I, II IIIA), preopera-
tive nodal staging by contrast enhanced CT scan, but mediastinal nodal 
metastasis than PET/CT, whereas PET/CT shows excellent speciﬁcity 
and sensitivities
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Background: The purpose of this study is to evaluate the prognostic 
importance of thin-section CT (TS-CT) ﬁndings in small-sized lung 
adenocarcinomas. 
Methods: We reviewed TS-CT ﬁndings and pathological specimens 
from 359 consecutive patients who underwent surgical resection for 
peripheral lung adenocarcinomas smaller than 20 mm in diameter dur-
ing the period from July 1997 to May 2006. By using TS-CT images, 
tumors were deﬁned as air-containing types if the maximum diameter 
of tumor opacity on mediastinal window images was less than or equal 
to half of that on lung window images, and as a solid-density type if 
the maximum diameter on mediastinal window images was more than 
half of that on lung window images. We compared TS-CT ﬁndings to 
pathological ﬁndings (lymph node metastasis, pleural invasion, vessel 
invasion, and lymphatic permeation) and prognosis. The following 
prognostic factors were analyzed by chi-square test and Cox propor-
tional hazard model: age, gender, tumor size, pathological stage, TS-CT 
ﬁndings, histologic subtypes deﬁned by Noguchi (Noguchi type), pleu-
ral involvement, lymphatic permeation, and vascular invasion. 
Results: No pathological invasive ﬁndings or recurrence were found in 
patients with air-containing type tumors. Pathological invasive ﬁndings 
and recurrence were found in 10% to 30% of patients with solid-den-
sity type tumors. The air-containing type on TS-CT and Noguchi type 
A or B were demonstrated as prognostic factors for good outcome by 
chi-square test (p<0.001). Multivariate analyses revealed lymphatic 
permeation as a signiﬁcant prognostic factor. 
Conclusions: The TS-CT ﬁndings were important predictive factors for 
postsurgical outcome in patients with lung adenocarcinoma.
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Background: Pulmonary imaging with hyperpolarized helium-3 (3He-
MRI) is emerging as an alternative to SPECT that has the potential to 
provide superior lung function information. In particular, ventilation 
and perfusion data from 3He-MRI may be used for functionally weight-
ed intensity modulated radiotherapy (IMRT) lung planning [1]. The 
aim of this study was to develop and evaluate an improved protocol for 
image registration of 3He-MRI to treatment planning x-ray CT.
Methods: An initial six NSCLC patients underwent 3He-MRI with a 
radiofrequency coil that required the patients to be imaged supine with 
their arms down, and a free breathing single-slice CT protocol for treat-
ment planning. The 3He gas was polarized on site to 30% and imaging 
was performed during a single 14s breath-hold of a 300ml 3He/700ml 
N2 mixture. Following the development of an elliptical birdcage 3He-
MRI coil [2] and the installation of a 16-slice CT, a further six patients 
were scanned. A new protocol was devised that enabled 3He-MRI to be 
acquired in treatment position and a planning CT to be acquired during 
an inspiration breath-hold performed with a 1L bag ﬁlled with room air 
that simulated the 3He-MRI breathing maneuver. For all images, 3He-
MRI to CT image fusion was performed using anatomical landmark 
based rigid registration which was assessed using the relative volume 
overlap [1]. 
Results: Over all slices, the original 3He-MRI and CT were regis-
tered with (mean±SD) overlap 73±11%. With the new equipment and 
modiﬁed imaging protocol, the overlap was signiﬁcantly improved to 
84±4% (p=0.05). 
